Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Clinical Research and Equipment Industry Analysis

UpdatedSep 30, 2025
DataAggregated Company Financials
Companies10
  • 7D6.9%
  • 3M8.8%
  • 1Y-17.1%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has risen 7.0%, driven by gains from EirGenix of 11%. In contrast, the industry has lost 17% in the last 12 months.

Industry Valuation and Performance

Has the Taiwanese Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 01 Oct 2025NT$36.9bNT$2.5b-NT$870,437,000.0019.8x-42.4x15x
Fri, 29 Aug 2025NT$34.9bNT$2.5b-NT$819,216,000.0020.5x-42.6x14.2x
Sun, 27 Jul 2025NT$34.9bNT$2.5b-NT$600,003,000.0021.9x-58.1x14.2x
Tue, 24 Jun 2025NT$33.1bNT$2.5b-NT$600,003,000.0022.8x-55.1x13.4x
Thu, 22 May 2025NT$32.3bNT$2.5b-NT$604,301,000.0023.2x-53.5x13.2x
Sat, 19 Apr 2025NT$31.6bNT$2.5b-NT$540,128,000.0024.3x-58.5x12.8x
Mon, 17 Mar 2025NT$36.1bNT$2.6b-NT$849,328,000.0029.2x-42.5x14x
Wed, 12 Feb 2025NT$38.0bNT$2.6b-NT$854,432,000.0023.5x-44.4x14.8x
Fri, 10 Jan 2025NT$35.9bNT$2.6b-NT$854,432,000.0023.2x-42x14x
Sun, 08 Dec 2024NT$40.7bNT$2.6b-NT$854,432,000.0023.8x-47.6x15.9x
Tue, 05 Nov 2024NT$42.8bNT$2.5b-NT$712,402,000.0024.4x-60.1x17.1x
Thu, 03 Oct 2024NT$41.9bNT$2.3b-NT$836,610,000.0022.3x-50x18.4x
Sat, 31 Aug 2024NT$41.6bNT$2.3b-NT$836,610,000.0022.2x-49.7x18.3x
Mon, 29 Jul 2024NT$42.7bNT$2.1b-NT$797,765,000.0033x-53.5x20x
Wed, 26 Jun 2024NT$42.0bNT$2.1b-NT$797,765,000.0033.9x-52.7x19.7x
Fri, 24 May 2024NT$40.0bNT$2.1b-NT$797,765,000.0032.1x-50.1x18.7x
Sun, 21 Apr 2024NT$38.2bNT$2.1b-NT$923,759,000.0030x-41.4x18.1x
Tue, 19 Mar 2024NT$39.8bNT$2.1b-NT$611,433,000.0032.2x-65x19.3x
Thu, 15 Feb 2024NT$43.0bNT$2.1b-NT$610,218,000.0032.4x-70.4x20.7x
Sat, 13 Jan 2024NT$44.9bNT$2.1b-NT$610,218,000.0033.3x-73.6x21.6x
Mon, 11 Dec 2023NT$48.2bNT$2.1b-NT$610,218,000.0033.6x-79.1x23.2x
Wed, 08 Nov 2023NT$49.5bNT$2.2b-NT$497,769,000.0032.3x-99.4x22.2x
Fri, 06 Oct 2023NT$48.9bNT$2.2b-NT$497,769,000.0031.3x-98.3x22x
Sun, 03 Sep 2023NT$43.9bNT$2.2b-NT$497,769,000.0031.8x-88.2x19.7x
Tue, 01 Aug 2023NT$47.5bNT$2.5b-NT$274,767,000.0043x-172.8x19.4x
Thu, 29 Jun 2023NT$50.1bNT$2.5b-NT$274,767,000.0043.3x-182.4x20.4x
Sat, 27 May 2023NT$50.0bNT$2.6b-NT$45,128,000.0043.4x-1107.2x19.1x
Mon, 24 Apr 2023NT$47.3bNT$2.7b-NT$29,761,000.0023.7x-1590.9x17.8x
Wed, 22 Mar 2023NT$48.5bNT$2.6b-NT$28,959,000.0024.1x-1674.7x18.3x
Fri, 17 Feb 2023NT$51.9bNT$2.7bNT$85.3m19.7x609x19.4x
Sun, 15 Jan 2023NT$45.2bNT$2.7bNT$85.3m18.9x529.9x16.9x
Tue, 13 Dec 2022NT$56.9bNT$2.7bNT$139.5m18.9x407.7x21.3x
Thu, 10 Nov 2022NT$43.1bNT$3.0bNT$480.6m23.4x89.7x14.4x
Sat, 08 Oct 2022NT$48.2bNT$3.0bNT$482.8m24.6x99.9x16.1x
Price to Earnings Ratio

99.9x


Total Market Cap: NT$48.2bTotal Earnings: NT$482.8mTotal Revenue: NT$3.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Clinical Research and Equipment Industry Price to Earnings3Y Average -89.8x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 17.8x is higher than the industry's current PS ratio of 15.0x.
Past Earnings Growth
  • Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 6.4% per year, which is driving profits down.

Industry Comparison

How does Taiwanese Clinical Research and Equipment compare with similar industries?

TW Market-2.59%
Healthcare-0.12%
Life Sciences6.85%
Clinical Research and Equipment6.85%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6589 EirGenixNT$70.3016.0%
+NT$2.9b		-20.5%PS22.2x
6891 Locus CellNT$34.7010.9%
+NT$680.0m		25.7%PS1340.8x
6986 HeXun BiosciencesNT$64.000.9%
+NT$27.6m		-16.2%PE22.4x
6939 TFBS BioscienceNT$26.202.7%
+NT$24.5m		-31.1%n/a
6662 BioLASCO TaiwanNT$33.501.1%
+NT$9.0m		-7.7%PE17.6x

Latest News

6848
NT$18.25
RBC Bioscience
7D
1.4%
1Y
2.4%
6661
NT$22.30
Welgene BiotechLtd
7D
0.2%
1Y
-11.3%
6891
NT$34.70
Locus Cell
7D
10.9%
1Y
25.7%
6939
NT$26.20
TFBS Bioscience
7D
2.7%
1Y
-31.1%
6662
NT$33.50
BioLASCO Taiwan
7D
1.1%
1Y
-7.7%
4133
NT$25.55
Abnova (Taiwan)
7D
-1.0%
1Y
-16.4%
6589
NT$70.30
EirGenix
7D
16.0%
1Y
-20.5%
6986
NT$64.00
HeXun Biosciences
7D
0.9%
1Y
-16.2%
7607
NT$14.05
DuoGenic StemCells
7D
-14.8%
1Y
-48.0%